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Abstract
Background: Two-dimensional, unidirectionally encoded, cardiovascular magnetic resonance (CMR)
velocity mapping is an established technique for the quantification of blood flow in large vessels. However,
it requires an operator to correctly align the planes of acquisition. If all three directional components of
velocity are measured for each voxel of a 3D volume through the phases of the cardiac cycle, blood flow
through any chosen plane can potentially be calculated retrospectively. The initial acquisition is then more
time consuming but relatively operator independent.
Aims: To compare the curves and volumes of flow derived from conventional 2D and comprehensive 3D
flow acquisitions in a steady state flow model, and in vivo through planes transecting the ascending aorta
and pulmonary trunk in 10 healthy volunteers.
Methods: Using a 1.5 T Phillips Intera CMR system, 3D acquisitions used an anisotropic 3D segmented
k-space phase contrast gradient echo sequence with a short EPI readout, with prospective ECG and
diaphragm navigator gating. The 2D acquisitions used segmented k-space phase contrast with prospective
ECG and diaphragm navigator gating. Quantitative flow analyses were performed retrospectively with
dedicated software for both the in vivo and in vitro acquisitions.
Results: Analysis of in vitro data found the 3D technique to have overestimated the continuous flow rate
by approximately 5% across the entire applied flow range. In vivo, the 2D and the 3D techniques yielded
similar volumetric flow curves and measurements. Aortic flow: (mean ± SD), 2D = 89.5 ± 13.5 ml & 3D =
92.7 ± 17.5 ml. Pulmonary flow: 2D = 98.8 ± 18.4 ml & 3D = 94.9 ± 19.0 ml). Each in vivo 3D acquisition
took about 8 minutes or more.
Conclusion: Flow measurements derived from the 3D and 2D acquisitions were comparable. Although
time consuming, comprehensive 3D velocity acquisition could be relatively operator independent, and
could potentially yield information on flow through several retrospectively chosen planes, for example in
patients with congenital or valvular heart disease.
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Phase contrast velocity mapping using cardiovascular
magnetic resonance (CMR) gives quantitative informa-
tion of the blood flow in a given vessel and can be per-
formed on a 2D slice or in a 3D volume. The 2D flow
measurement is a well established technique for cardio-
vascular blood flow quantification [1-3]. The approach
utilizes 2D slice planes, which must be positioned during
scanning requiring a high degree of operator skill. How-
ever, by utilizing a 3D phase contrast technique [4,5], the
entire heart can be imaged using a 3D volume. Planning
of the cardiac scan is hereby reduced to placing a 3D box
around the heart, hereby making the acquistion more
operator independent. Interactive postprocessing may be
used to quantify the blood flow in any arbitrary image
plane. This convenient off-line flow evaluation in any
imaging plane may overcome the inherent problems
related to possible misalignment errors in 2D flow [6].
Besides yielding quantitative information of cardiac glo-
bal function (cardiac output, stroke volume, ejection fraction)
the 3D approach (also known as 7D cardiac scan) include
qualitative information of the general flow patterns in the
cardiac cavities [7], heart valve function (stenosis, regurgita-
tion) [8] and thoracic aortic flow [9-11]. The visualization
of 3D flow patterns by so-called streamlines, arrows or
particle paths are based on 3D phase contrast images [12]
and have been applied to several regions of the vascular
tree [13-15]. Thus, the 3D approach possesses the capacity
to provide valuable information that is not available with
a 2D technique.
The proposed 3D technique enables automatic slice refor-
matting in the 3D flow data set, which matches the imag-
ing plane of any arbitrary 2D morphological or functional
acquisition. This merging of 3D flow and anatomic
images may prove to be a valuable imaging strategy,
which can be exploited qualitatively as well as quantita-
tively. A qualitative aspect is the coloring of the blood
flow according to its direction. By doing so, the possibility
to differentiate between arteries and veins in the aligned
acquisition is enabled. If a morphological scan raises
uncertainty regarding the flow direction of a vessel, the 3D
flow sequence can provide information otherwise not
available. The quantitative aspect possesses the ability to
yield accurate flow values through a plane arbitrarily ori-
ented in the acquired 3D volume. Therefore, isotropic 3D
whole heart flow measurements may facilitate integration
of functional, morphological and quantitative evaluation
of complex congenital heart diseases as well as acquired
heart diseases [6].
We sought to compare flow curves and volumes derived
from conventional 2D and comprehensive 3D CMR phase
contrast flow acquisitions in a steady state flow model,
and in vivo through planes transecting the ascending aorta
and pulmonary trunk in healthy volunteers.
Materials and methods
Ten healthy volunteers (two women and eight men; age
29 ± 7 years) were enrolled in the study. The study was
conducted on a whole body 1.5 Tesla Philips Intera CMR
system (Philips, Best, The Netherlands) with PowerTrack
6000 gradients. All volunteers underwent the entire CMR
examination during a 90–120 minute period, which
included subject preparation, scanner set-up and CMR
imaging. All data were acquired in the same examination
session to ensure comparability.
In vivo blood flow measurements were made with a three-
dimensional, three-directional phase contrast velocity
mapping sequence. The 3D volume was placed in such a
way that it covered all of the heart from the apex to the
basis including the large thoracic arteries being investi-
gated. Thus, the entire heart was covered with an isotropic
spatial resolution of 3.0 × 3.0 × 3.0 mm3. All three velocity
components were measured by acquiring one segment
with no velocity sensitivity and three segments with veloc-
ity sensitivity in each direction. Due to the duration of the
3D scans, breath holding was not possible. Instead data
acquisition was combined with prospective ECG and dia-
phragm navigator gating during free breathing with an 8
mm gating window. The 3D flow sequence was a seg-
mented k-space phase-contrast gradient echo sequence (4
k-lines per heart-phase) with a short EPI readout (EPI fac-
tor = 5), hence 20 k-lines were acquired per heart phase.
TR was 7.6 ms, TE was 4.3 ms, SENSE factor was 1.60 in
AP direction and 1.60 in RL direction, flip angle 10°,
matrix size 128 × 128, 50 slices and the velocity encoding
was set to 150 cm/s. The 3D images were acquired in
approximately 8 minutes or more with a navigator effi-
ciency of 50%
The 3D CMR technique was compared with a conven-
tional segmented k-space (factor = 3) 2D prospective ECG
and diaphragm navigator gated flow sequence with a non-
isotropic spatial resolution of 1.41 × 1.41 mm2 and a slice
thickness of 5 mm. The flip angle was 25°, TR = 6.4 ms,
TE = 3.3 ms, the matrix size was 256 × 256 and 2 signal
averages were acquired. The 2D slices were placed approx-
imately 3 cm above the aortic and the pulmonary valves
respectively. Both scan techniques used prospective trig-
gering and the navigator was played out for 35 ms at the
beginning of each cardiac cycle. The 2D images were
acquired in approximately 3 minutes or more with a nav-
igator efficiency of 50%.
The 3D flow measurements were acquired with a tempo-
ral resolution of 55 ± 12 ms (20 images per cardiac cycle)Page 2 of 7
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ments was 36 ± 9 ms (29.7 ± 3.7 images per cardiac cycle).
In vitro experiments were performed using a closed pump-
ing circuit consisting of a water pump and a silicone tube.
The tube was surrounded by stationary water as reference
in the isocenter of the magnet. Manganese chloride (0.1 g/
L) was added to the steady flowing water to improve the
signal intensity at short repetition times. Before each data
acquisition the in vitro system was manually calibrated
with known flow values ranging from 2307 ml/min to
7250 ml/min to simulate realistic blood flow values. This
manual flow estimation step was carried out by using a
stop watch and a scale. The average of three consecutive
manual flow measurements was then used as the true flow
value when compared to the CMR obtained flow values.
The imaging parameters of the acquired images were iden-
tical to the in vivo experiment. Immediately after each cal-
ibration, sets of paired observations were obtained using
the 2D and 3D CMR methods respectively.
Data Evaluation
All data analyses were done by dedicated computer soft-
ware developed for this study. Based on information of
position and orientation from the acquisitions, the soft-
ware automatically aligned the 2D flow slices into the 3D
flow volume. The position in the 3D data set was visually
compared with the 2D slice before analyses were per-
formed. If the position in the 3D data set was not perfectly
matched, the software allowed the user to manually
change the position in the 3D flow data set. To ease this
step a 3D morphology scan was used to visually guide the
user to match the 2D and 3D flow analysis (Fig. 1).
Regions of interest (ROI) could then be placed on the
ascending aorta and the pulmonary arteries and the flow
values calculated.
Data were evaluated for normality by quantile-quantile
plots and statistical comparisons of the 2D and 3D meth-
ods were done by paired t-tests and by Bland & Altman
plots. All statistical analyses were performed in Microsoft
Excel 2003 with the statistical add-in tool pack Analyse-It®
Software, Ltd (Version 1.73). All results are presented as
mean ± standard deviation. P values ≤ 0.05 were consid-
ered statistically significant.
Results
The 2D in vitro flow measurements were not different
from the true flow measured by bucket and stopwatch (p
= 0.30). However, the 3D flow estimations were signifi-
cantly higher than the true flow (p = 0.004) with a mean
difference of approximately 5% (275 ± 168 ml/min). The
overestimation of the 3D flow measurements was present
in the entire flow range as indicated by Figure 2. A signif-
icant difference was also found between the 2D and 3D
flow techniques (p = 0.020). The 3D flow was 4% higher
than the 2D flow (mean difference 214 ± 189 ml/min).
Seventeen complete data sets were successfully obtained
from the volunteers in the in vivo experiments. Aortic flow
data from one volunteer was rejected due to a faulty 2D
slice placement directly on top of the aortic valve. A 3D
flow data set was rejected from one subject due to an ECG-
triggering fault, which made 3D data acquisition impossi-
ble. All measured flow data are presented in Table 1.
The 3D and the 2D flow images were acquired in 503.7 ±
39.3 seconds and 162.6 ± 54.8 seconds respectively.
Results from the aortic flow measurements yielded 2D
stroke values of 89.5 ± 13.5 ml/stroke and 3D stroke val-
ues of 92.7 ± 17.5 ml/stroke (p = 0.68, mean difference
4.0 ± 8.8 ml). The pulmonary flow data resulted in a 2D
stroke volume of 98.8 ± 18.4 ml/stroke and a 3D stroke
volume of 94.9 ± 19.0 ml/stroke (p = 0.67, mean differ-
ence 3.2 ± 16.2 ml).
The results show no statistical differences between the 3D
and 2D in vivo flow measurements. Bland & Altman plots
of the data did not suggest that a systematic difference was
present in the acquired data as indicated by the data point
distribution (Fig. 3).
Discussion
In Vitro Study
The applied 2D phase-contrast sequence follows the pro-
tocol prescription described by Bakker et al [16]. The
robustness of the 2D technique is supported by the find-
ings of Chatzimavroudis et al [17] as well as our in vitro
data. Our results from the in vitro study suggest that the
presented 3D technique overestimates the true steady
state flow by approximately 5%. This overestimation
seems to apply along the entire range of the applied flow
values as indicated by Figure 2. Several systematic errors
may have contributed to this including eddy currents,
Maxwell terms error, partial volume effects and gradient
non-linearities.
However, the data reported in our in vitro study does not
necessarily apply to the in vivo situation for several rea-
sons. The water used in our study is an imperfect substi-
tute for human blood and the flow system utilized
laminar steady state flow rather than pulsatile. Thus, a
direct comparison of our in vitro and in vivo data may be
somewhat misleading and care must be taken when eval-
uating the precision of the applied 3D flow protocol in
vivo.
In a clinical setting an error of up to 10% can be expected
using 2D phase contrast measurements [1]. We found an
overestimation with the 3D protocol of approximately 5%Page 3 of 7
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(A), a volume rendered morphological 3D viewFigure 1
(A), a volume rendered morphological 3D view. (B) 2D phase contrast image of the aortic blood. (C) Alignment of the 
2D slice in (B) into the 3D flow volume. In-plane flow of the 3D flow acquisition is described by a green color component. (D) 
Same slice as in (C) showing the through-plane components of the 3D flow acquisition in blue/red. (E) Flow curves from the 
2D flow scan in (B) and the aligned slice from the 3D flow scan in (D). Abbreviations: AA: Ascending Aorta. DA: Descending 
Aorta. PA: Pulmonary Artery.
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fore argue that this increase is acceptable and the 3D tech-
nique is a feasible approach for operator-independent
flow imaging.
In Vivo Study
Our in vivo results suggest that the two blood flow meas-
urement methods provide similar flow results. Qualitative
3D flow techniques have been implemented in a variety of
clinical areas including the great vessels, the thoracic
aorta, the left ventricle and the outflow tract, the left
atrium, and the aortic valve. Several studies have validated
3D flow against the conventional 2D approach [18,19].
The feasibility of using isotropic 3D CMR data has already
been shown on morphological data [20]. However, this
study aims to enhance this approach to include flow data.
By using isotropic voxels, the 3D technique may be truly
operator independent and all imaging planes are acquired
during a single acquisition as shown in this study. Our 3D
approach had a lower spatial and temporal resolution as
compared to previous studies [18,19]. In the future, this
may be overcome by improvements in hardware and soft-
ware, e.g. using parallel imaging and under sampling
methods such as k-t SENSE [21-23]. Due to the use of nav-
igator corrected respiratory motion compensation,
approximately 77 ms of the initial cardiac cycle was not
measured. Therefore we had to interpolate the first time
point in the flow curve.
Scan time
The scan time of the 3D technique is rather long com-
pared to the applied 2D protocol. This is in concordance
with previous studies [18,19]. However, in order to accu-
rately quantify blood flow, the 2D slice must be placed
perpendicular to the vessel. To do this, one or more refer-
ence images must be taken to ensure that the slice is cor-
rectly angulated. Thus, to obtain a 2D flow measurement
of the pulmonary artery and the aorta, a minimum of four
scans must be acquired. By using 3D acquisition with iso-
tropic voxels, a single 3D volume can be placed around
the entire heart, obviating the need for reference scans and
therefore the total examination time will only be slightly
increased as compared to the traditional method.
Spatial resolution
One disadvantage of the 3D method is the lower spatial
resolution as compared with the traditional 2D approach.
This limitation is dictated by the scan time limitation. The
lower spatial resolution will, of course, render more
blurry images than for 2D, but for accurate flow assess-
ment in larger vessel high spatial resolution is not critical.
As shown by Hofman et al [24], the volume flow can be
accurately determined as long as there are more than 3
pixels across the vessel. Thus, with a 3 mm isotropic reso-
lution, the flow can be accurately determined in vessels
with a diameter larger than 9 mm.
Study limitations
The use of a single velocity encoding range for all regions
of the 3D volume may be suboptimal if regions of high
Graph showing the paired flow in vitro values using the 2D and 3D techniquesFigure 2
Graph showing the paired flow in vitro values using 
the 2D and 3D techniques. The dotted line represents 
the true flow.
Table 1: Results from the 2D and 3D in vivo flow data
Volunteer
#
2D Aortic Flow [ml/stroke] 3D Aortic Flow
[ml/stroke]
2D Pulmonary Flow
[ml/stroke]
3D Pulmonary Flow
[ml/stroke]
1 81.93 75.92 81.17 80.71
2 91.42 84.39 89.94 77.34
3 81.56 65.68 70.04 60.66
4 76.64 86.77 70.17 104.23
5 118.66 112.72 104.39 107.24
6 111.03 114.87 90.82 115.24
7 124.27 111.13 104.24 91.01
8 105.1 107.28 103.68 106.28
9 113.5a 82.49 90.77 91.59
10 95.48 -b 90.56 -b
a Data rejected due to a faulty 2D slice placement directly on top of the aortic valve
b Data rejected due to ECG-triggering failure during data acquisitionPage 5 of 7
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velocity venous or arterial flows. The use of prospective
ECG gating fails to provide information on late diastolic
(atrial systolic) flow. Furthermore, there was slight loss of
data on early systolic arterial flow due to the pre-systolic
placement of the navigator pulse. Late diastolic navigator
placement may therefore be preferable in most cases.
Finally, until robust and user-friendly software becomes
available commercially, expert and time consuming post
processing of 3D data is needed.
Conclusion
Three dimensional, three directionally encoded velocity
mapping offers a relatively comprehensive and operator
independent but more time consuming method for deriv-
ing curves and volumes of flow through retrospectively
chosen planes of measurement. Aortic and pulmonary
flow measurements compared well with those from con-
ventional 2D, through-plane velocity acquisitions in the
volunteers studied. Subject to the limitations outlined, the
comprehensive 3D approach has the potential to be of
clinical value in patients with congenital or valvular heart
disease, for example in the presence of shunts or other car-
diovascular malformations.
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